William Shatner made history as the oldest living person to travel to space when he flew on Jeff Bezos’ Blue Origin space shuttle on Oct. 13, 2021.
Author: Editorial Staff
Spero Health Brings Relief for Addiction and Lifesaving Care to Thousands in 2022
Spero Health released a 2022 organizational summary of the impact their outpatient addiction treatment program has had on communities struggling with the drug epidemic.
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
Tempus, a leader in artificial intelligence and precision medicine, today announced a prospective study NCT05257551, in collaboration with AstraZeneca.
iSun Inc. completes $16.4 million transaction of development project
iSun, Inc. is a leading solar energy and clean mobility infrastructure company with 50-years of experience accelerating the adoption of innovative electrical technologies.
HeartBeam Granted European Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG)
HeartBeam, Inc. announced today that its patent that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo™ credit card-sized device was issued by the European Patent Office.
Sidus Space Enters Pivotal Year Building on a Strong Foundation of Achievements in 2022
Sidus Space, Inc. is, a Space-as-a-Service company focused on mission-critical hardware manufacturing combined with commercial satellite design, manufacture, launch, and data collection.
Magnolia Oil & Gas Announces Preliminary Fourth Quarter 2022 Production
Magnolia Oil & Gas Corporation (NYSE: MGY) announced preliminary fourth quarter 2022 estimated oil and gas production volumes in the range of 73 to 74 Mboe per day, compared to the midpoint of the Company’s earlier guidance of 78 Mboe per day.
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
Cardiovascular Systems, Inc. announced today that Innova Vascular, Inc. (Innova) has submitted a 510(k) Premarket Notification to the U.S. Food and Drug Administration (FDA) for its thrombectomy devices intended to treat peripheral vascular disease.
Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company
Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approval of each company’s stockholders at respective special meetings of stockholders held today.
